🔎 Trials Near Me

Hem › Steatotisk leversjukdom › Texas › Houston

Kliniska studier för Steatotisk leversjukdom i Houston, TX

13 studier för Steatotisk leversjukdom söker deltagare vid platser i och runt Houston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RekryterarFas 3
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
Ålder 18 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RekryterarFas 3
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • 89bio Clinical Study Site, Houston
  • och 1 fler
Ålder 18 till 80 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06318169

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

RekryterarFas 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Bellaire · 7 mi bort
  • GSK Investigational Site, Humble · 17 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

RekryterarFas 3
  • GSK Investigational Site, Bellaire · 7 mi bort
  • GSK Investigational Site, Humble · 17 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07701993

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RekryterarFas 3
  • HRI- Medical Center, Houston
  • Care Access - Houston, Houston
  • Houston Research Institute, Houston
  • och 3 fler
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RekryterarFas 3
  • Akero Clinical Study Site, Houston
  • Akero Clinical Study Site, Houston
  • Akero Clinical Study Site, Houston
  • och 3 fler
Ålder 18 till 80 · Alla kön · Uppdaterad 21 sep. 2026 · NCT06528314

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

RekryterarFas 2
  • Houston Research Institute - Medical Center, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, Bellaire · 7 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 9 sep. 2026 · NCT07288138

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

RekryterarFas 3
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Bellaire · 7 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 27 juli 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

RekryterarFas 2
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
  • GSK Investigational Site, Houston
Ålder 18 till 75 · Alla kön · Uppdaterad 8 juli 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

RekryterarFas 1/2Friska volontärer välkomna
  • Pioneer Research Solutions, Houston
Ålder 18 till 75 · Alla kön · Uppdaterad 16 apr. 2026 · NCT05648214

NAFLD Clinical Care Pathway

RekryterarFriska volontärer välkomna
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Ålder 18 och äldre · Alla kön · Uppdaterad 14 nov. 2025 · NCT06671886

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

RekryterarObservationsstudie
  • First Surgical Hospital, Bellaire · 7 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 14 aug. 2025 · NCT07122700

Steatotisk leversjukdom-studier i andra städer

Andra studier i Houston

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.